A comparative review of stability testing, analytical procedure validation and analytical procedure development under ICH guidelines

Pharmaceutical analytical procedures must provide reliable results throughout the product lifecycle while meeting regulatory, scientific, environmental, and practical requirements. The International Council for Harmonisation (ICH) guidelines Q1A(R2), Q2(R2), and Q14 provide complementary frameworks for stability testing, analytical procedure validation, and analytical procedure development, respectively. This review aims to provide a systematic comparison of ICH Q1A(R2), Q2(R2), and Q14 and to discuss their integration with Analytical Quality by Design (AQbD) and emerging multicoloured analytical chemistry approaches. Relevant literature and regulatory guidance were reviewed to compare the principles, objectives, testing requirements, validation characteristics, development strategies, and lifecycle considerations associated with these guidelines. Recent applications of AQbD, Design of Experiments (DoE), and Red–Green–Blue/White Analytical Chemistry (RGB/WAC) were also evaluated in terms of analytical performance, environmental sustainability, and practical applicability. ICH Q1A(R2) provides a framework for evaluating stability and establishing appropriate storage conditions and shelf life, whereas Q2(R2) provides principles for demonstrating the suitability of analytical procedures for their intended purpose. ICH Q14 introduces a science- and risk-based approach to analytical procedure development, supporting systematic development, robustness, and lifecycle management. AQbD, supported by risk assessment, DoE, and Method Operable Design Region (MODR), further strengthens analytical procedure development. RGB/WAC approaches provide complementary assessment of analytical performance, environmental impact, and practical applicability. Integration of stability assessment, analytical validation, systematic procedure development, AQbD, and complementary sustainability frameworks can support robust, reliable, and lifecycle-oriented pharmaceutical analysis while addressing regulatory, environmental, and practical considerations.